- Home
- SRG vs TNYA Comparison
SRG vs TNYA Comparison
Compare SRG & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.35
HOLD
Current Price
$0.69
Company Overview
Basic Information| Metric | SRG | TNYA |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.0M | 234.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SRG | TNYA |
|---|---|---|
| Price | $3.35 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 176.4K | ★ 6.8M |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,406,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.43 | $0.36 |
| 52 Week High | $4.56 | $2.35 |
Technical Indicators
Market Signals| Indicator | SRG | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 26.42 |
| Support Level | $3.38 | $0.79 |
| Resistance Level | $3.68 | $1.46 |
| Average True Range (ATR) | 0.13 | 0.10 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 16.33 | 3.33 |
Price Performance
Historical Comparison SRG
TNYA
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.